–
[SABC 방송 화면 캡처, 가운데가 라마포사 대통령, 왼쪽이 마부자 부통령] Resale and DB ban
–
(Cairo = Yonhap News) Correspondent Kim Sang-hoon = South Africa has decided to withhold the use of the AstraZeneca vaccine, which has been evaluated as having limited preventive effect against the mutant virus from South Africa, Reuters reported on the 7th (local time).
South African Health Minister Zwelly Mkije said he would withhold the use of the AstraZeneca vaccine from the immunization program and wait for advice from scientists to ensure the best possible vaccination.
The South African government plans to provide Johnson & Johnson and Pfizer vaccines while waiting for the scientists’ judgment.
Previously, researchers from Oxford University and South Africa’s University of Bittersland conducted phase 1 and 2 trials on 2,26 people, and found that two doses of the AstraZeneca vaccine could not prevent mild and moderate symptoms caused by mutations in South Africa. The results of the study were presented.
–
[AP=연합뉴스 자료사진]
–
The effects of the South African mutation in preventing serious illness or hospitalization or death cannot yet be determined, the researchers said.
However, the University of Oxford said that the AstraZeneca-Oxford University vaccine was effective against the UK mutation.
South Africa previously received 1 million doses of the first shipment of the AstraZeneca vaccine produced by the Serum Institute (SII) in India on the 1st.
South Africa decided to start vaccinating medical staff within two weeks after going through the relevant procedures at the time.
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2021/02/08 05:22 sent
–
